These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 16437573

  • 1. Neurological impact of vasopressin dysregulation and hyponatremia.
    Bhardwaj A.
    Ann Neurol; 2006 Feb; 59(2):229-36. PubMed ID: 16437573
    [Abstract] [Full Text] [Related]

  • 2. Vasopressin antagonists: role in the management of hyponatremia.
    Yeates KE, Morton AR.
    Am J Nephrol; 2006 Feb; 26(4):348-55. PubMed ID: 16837788
    [Abstract] [Full Text] [Related]

  • 3. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
    LeJemtel TH, Serrano C.
    Int J Cardiol; 2007 Aug 09; 120(1):1-9. PubMed ID: 17346825
    [Abstract] [Full Text] [Related]

  • 4. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
    Rai A, Whaley-Connell A, McFarlane S, Sowers JR.
    Am J Nephrol; 2006 Aug 09; 26(6):579-89. PubMed ID: 17170524
    [Abstract] [Full Text] [Related]

  • 5. Vasopressin excess and hyponatremia.
    Pham PC, Pham PM, Pham PT.
    Am J Kidney Dis; 2006 May 09; 47(5):727-37. PubMed ID: 16632011
    [Abstract] [Full Text] [Related]

  • 6. Hyponatremia and hypernatremia: disorders of water balance.
    Agrawal V, Agarwal M, Joshi SR, Ghosh AK.
    J Assoc Physicians India; 2008 Dec 09; 56():956-64. PubMed ID: 19322975
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hyponatremia in neurologic patients: consequences and approaches to treatment.
    Diringer MN, Zazulia AR.
    Neurologist; 2006 May 09; 12(3):117-26. PubMed ID: 16688013
    [Abstract] [Full Text] [Related]

  • 10. Vasopressin antagonism: potential impact on neurologic disease.
    Rabinstein AA.
    Clin Neuropharmacol; 2006 May 09; 29(2):87-93. PubMed ID: 16614541
    [Abstract] [Full Text] [Related]

  • 11. Hyponatremia in the neurosurgical patient: epidemiology, pathophysiology, diagnosis, and management.
    Fraser JF, Stieg PE.
    Neurosurgery; 2006 Aug 09; 59(2):222-9; discussion 222-9. PubMed ID: 16883162
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms, risks, and new treatment options for hyponatremia.
    Ghali JK.
    Cardiology; 2008 Aug 09; 111(3):147-57. PubMed ID: 18434717
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hyponatremia in psychiatric patients: update on evaluation and management.
    Siegel AJ.
    Harv Rev Psychiatry; 2008 Aug 09; 16(1):13-24. PubMed ID: 18306096
    [Abstract] [Full Text] [Related]

  • 16. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis.
    Robertson GL.
    Am J Med; 2006 Jul 09; 119(7 Suppl 1):S36-42. PubMed ID: 16843083
    [Abstract] [Full Text] [Related]

  • 17. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R.
    Nefrologia; 2008 Jul 09; 28 Suppl 3():87-93. PubMed ID: 19018744
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vasopressin receptor antagonists: potential indications and clinical results.
    Arai Y, Fujimori A, Sudoh K, Sasamata M.
    Curr Opin Pharmacol; 2007 Apr 09; 7(2):124-9. PubMed ID: 17292670
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.